Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

NIH awards SBIR grant to BioSante to develop pulmonary delivery of IFN-alpha

Nov. 18, 2008

Athersys achieves development milestone in Bristol-Myers discovery alliance

Nov. 17, 2008

Telik enters discovery agreement for musculoskeletal and autoimmune diseases

Nov. 14, 2008

SurModics acquires drug delivery technology from PR Pharmaceuticals

Nov. 6, 2008

MonoSol and Midatech sign agreement to develop therapeutic nanoparticles in thin film

Nov. 5, 2008

BioWa licenses Potelligent to KaloBios

Oct. 30, 2008

New drug delivery agents reported in recent Emisphere Technologies patent

Oct. 24, 2008

RXi licenses rights from UMMS to technology for oral delivery of RNAi therapeutics

Oct. 16, 2008

BioWa and CSL sign license agreement for Potelligent technology in ADCC-enhanced antibodies

Oct. 14, 2008

Affymetrix and MPI sign agreement for Affymetrix microarray technology in cancer

Oct. 6, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...